Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-04-10
1998-12-29
Spivack, Phyllis
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31495
Patent
active
058542485
ABSTRACT:
Nefazodone and its pharmaceutically acceptable salts are useful in prophylactic treatment of recurrent headache disorders, as, in particular, vascular and migraine headaches.
REFERENCES:
patent: 4338317 (1982-07-01), Temple et al.
patent: 5116852 (1992-05-01), Gammans
Chemical Abstracts, vol. 116, No. 17, Potentiation of opioid analgesia by the antidepressant nefazodone. Apr. 1992. Abrstract No. 166183a. Pick et al. page 62. Eur. J. Pharmacol., 211(3), 375-381.
USP Dictionary of USAN and International Drug Names, 1995, p. 459.
D.P. Taylor, et al, "Nefazodone Hydrochloride," Drugs of the Future, 12(8), pp. 758-759 (1987).
A. Eison, et al, "Nefazodone: Preclinical Pharmacology of a New Antidepressant," Psychopharmacology Bulletin, 26(3), pp. 311,315 (1990).
Nappi, et al., Headache, 30, 1990: pp. 438-444.
Foster, et al., Headache, 34, 1994: pp. 587-589.
Silberstein, et al., and Spierings, Headache, 32, 1992: pp. 242-244.
Workman, et al., Am. J. Psychiatry, 149:5, 1992: pp. 712-713.
Marcus Ronald N.
Sussman Neil M.
Bristol--Myers Squibb Company
Ryan Richard P.
Spivack Phyllis
LandOfFree
Nefazodone: use in migraine prophylaxis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nefazodone: use in migraine prophylaxis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nefazodone: use in migraine prophylaxis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1425088